SCHEMBL17346368

SCHEMBL17346368

CCN(CCNCCSCc1ccccc1)Cc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAOB P27338 3/20 0.42
APP P05067 3/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
LMNA P02545 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ACKR3 P25106 1/20 0.40
MEN1 O00255 2/20 0.40
MAPT P10636 1/20 0.40
KMT2A Q03164 1/20 0.40
KDM4E B2RXH2 1/20 0.40
CNR2 P34972 1/20 0.40
BCHE P06276 2/20 0.39
ACHE P22303 2/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
OPRM1 P35372 1/20 0.39
OPRK1 P41145 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17345882 0.93 ALDH1A1 (0.44) ALDH1A1HPGDLMNASMN1; SMN2MEN1
SCHEMBL17345973 0.91 ALDH1A1 (0.45) ALDH1A1HPGDLMNASMN1; SMN2MEN1
SCHEMBL17346379 0.90 HRH3 (0.42) ALDH1A1HPGDLMNASMN1; SMN2ACKR3
SCHEMBL17345888 0.89 KCNH2 (0.41) ALDH1A1HPGDLMNASMN1; SMN2MEN1
SCHEMBL17346371 0.88 ACKR3 (0.45) ALDH1A1HPGDLMNASMN1; SMN2ACKR3
SCHEMBL17346065 0.86 APP (0.48) MAOBAPPACKR3BCHEACHE
SCHEMBL17345883 0.86 KCNH2 (0.48) ALDH1A1HPGDLMNASMN1; SMN2MEN1
SCHEMBL17346428 0.85 ALDH1A1 (0.43) ALDH1A1HPGDLMNASMN1; SMN2MEN1
SCHEMBL17346229 0.85 MAOB (0.43) MAOBAPPMEN1KDM4ECNR2
SCHEMBL17346378 0.83 LMNA (0.47) ALDH1A1HPGDLMNASMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10550139-B2 Polydentate ligands and their complexes for molecular catalysis TRIAD NATIONAL SECURITY, LLC (US) 2020-02-04 US disclosed
US-20170088571-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS TRIAD NATIONAL SECURITY, LLC 2017-03-30 US disclosed
US-20170088571-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS TRIAD NATIONAL SECURITY, LLC 2017-03-30 US disclosed
WO-2015191505-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS LOS ALAMOS NATIONAL SECURITY, LLC (US) 2015-12-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170088571-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS NANS, NCL, NCLN MAOB 3256/4885APP 3054/4885ALDH1A1 862/4885
US-10550139-B2 Polydentate ligands and their complexes for molecular catalysis NANS, NCL, NCLN MAOB 3256/4885APP 3054/4885ALDH1A1 862/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.